Physician profile
Aaron Wayne Sable
NPI 1306856984
$1,880.24
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $533 · 2020: $429 · 2021: $452 · 2022: $467.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $457.64 | 2019-2022 | |
| Allergan, INC. | $331.33 | 2019-2022 | |
| Abbvie INC. | $210.40 | 2021-2022 | |
| Indivior INC. | $134.36 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $122.92 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $96.62 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $96.35 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $76.11 | 2021-2022 | |
| Pfizer INC. | $57.40 | 2019-2021 | |
| Amgen INC. | $35.23 | 2019 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $27.95 | 2022 | |
| Mdd US Operations, LLC | $27.18 | 2019 | |
| Grt US Holding, INC. | $26.57 | 2020-2022 | |
| Ipsen Biopharmaceuticals, INC | $24.19 | 2019 | |
| Idorsia Pharmaceuticals US INC | $24.13 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $23.67 | 2019 | |
| Lilly USA, LLC | $23.37 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.13 | 2019 | |
| Hikma Pharmaceuticals USA | $14.77 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.21 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $12.41 | 2019 | |
| Horizon Therapeutics Plc | $12.06 | 2022 | |
| Kaleo, INC. | $11.24 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Sable listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.